Structure

Physi-Chem Properties

Molecular Weight:  384.08
Volume:  349.084
LogP:  1.041
LogD:  0.2
LogS:  -4.012
# Rotatable Bonds:  0
TPSA:  121.14
# H-Bond Aceptor:  8
# H-Bond Donor:  4
# Rings:  7
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.493
Synthetic Accessibility Score:  6.453
Fsp3:  0.4
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.063
MDCK Permeability:  2.344140739296563e-05
Pgp-inhibitor:  0.006
Pgp-substrate:  0.998
Human Intestinal Absorption (HIA):  0.082
20% Bioavailability (F20%):  0.015
30% Bioavailability (F30%):  0.933

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.386
Plasma Protein Binding (PPB):  69.50344848632812%
Volume Distribution (VD):  0.565
Pgp-substrate:  30.555130004882812%

ADMET: Metabolism

CYP1A2-inhibitor:  0.018
CYP1A2-substrate:  0.91
CYP2C19-inhibitor:  0.018
CYP2C19-substrate:  0.797
CYP2C9-inhibitor:  0.025
CYP2C9-substrate:  0.422
CYP2D6-inhibitor:  0.004
CYP2D6-substrate:  0.151
CYP3A4-inhibitor:  0.032
CYP3A4-substrate:  0.512

ADMET: Excretion

Clearance (CL):  6.216
Half-life (T1/2):  0.318

ADMET: Toxicity

hERG Blockers:  0.205
Human Hepatotoxicity (H-HT):  0.788
Drug-inuced Liver Injury (DILI):  0.643
AMES Toxicity:  0.948
Rat Oral Acute Toxicity:  0.546
Maximum Recommended Daily Dose:  0.974
Skin Sensitization:  0.925
Carcinogencity:  0.828
Eye Corrosion:  0.003
Eye Irritation:  0.029
Respiratory Toxicity:  0.93

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC23807

Natural Product ID:  NPC23807
Common Name*:   OTPVNHGOMNEPSU-KZYZBILJSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  OTPVNHGOMNEPSU-KZYZBILJSA-N
Standard InCHI:  InChI=1S/C20H16O8/c21-8-4-5-11-15-13(8)16(24)17-18(25-17)20(15)27-10-3-1-2-7-9(22)6-12(23)19(26-11,28-20)14(7)10/h1-5,9,12,16-18,21-24H,6H2/t9-,12+,16+,17+,18+,19+,20-/m0/s1
SMILES:  O[C@H]1C[C@@H](O)[C@@]23c4c1cccc4O[C@]1(O3)c3c(O2)ccc(c3[C@H]([C@@H]2[C@H]1O2)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL447094
PubChem CID:   24899409
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000048] Tetralins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32546 ymf 1.01029 n.a. n.a. n.a. n.a. n.a. n.a. PMID[18479163]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT593 Organism Bursaphelenchus xylophilus Bursaphelenchus xylophilus Activity = 54.8 % PMID[550710]
NPT593 Organism Bursaphelenchus xylophilus Bursaphelenchus xylophilus Activity = 25.6 % PMID[550710]
NPT593 Organism Bursaphelenchus xylophilus Bursaphelenchus xylophilus Activity = 62.3 % PMID[550710]
NPT593 Organism Bursaphelenchus xylophilus Bursaphelenchus xylophilus Activity = 35.5 % PMID[550710]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC23807 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9571 High Similarity NPC271076
0.95 High Similarity NPC151704
0.95 High Similarity NPC472155
0.9433 High Similarity NPC472154
0.9296 High Similarity NPC173630
0.9231 High Similarity NPC288531
0.9078 High Similarity NPC193920
0.9007 High Similarity NPC472151
0.8926 High Similarity NPC306267
0.8926 High Similarity NPC20050
0.8882 High Similarity NPC183402
0.8824 High Similarity NPC1253
0.8824 High Similarity NPC100936
0.8786 High Similarity NPC138940
0.8758 High Similarity NPC193749
0.8733 High Similarity NPC272552
0.8733 High Similarity NPC233467
0.8733 High Similarity NPC322899
0.8733 High Similarity NPC469944
0.8733 High Similarity NPC46283
0.8733 High Similarity NPC44192
0.8733 High Similarity NPC134911
0.8733 High Similarity NPC226108
0.8726 High Similarity NPC103633
0.8718 High Similarity NPC11608
0.8718 High Similarity NPC297404
0.8707 High Similarity NPC155564
0.8707 High Similarity NPC248053
0.8707 High Similarity NPC102280
0.8699 High Similarity NPC138227
0.8699 High Similarity NPC168579
0.8699 High Similarity NPC76176
0.8699 High Similarity NPC469313
0.8649 High Similarity NPC15538
0.8649 High Similarity NPC473480
0.863 High Similarity NPC252169
0.863 High Similarity NPC37793
0.863 High Similarity NPC472451
0.8609 High Similarity NPC21902
0.8592 High Similarity NPC188555
0.8592 High Similarity NPC130496
0.8591 High Similarity NPC280945
0.8591 High Similarity NPC175976
0.8581 High Similarity NPC125755
0.8571 High Similarity NPC28440
0.8571 High Similarity NPC171932
0.8562 High Similarity NPC472353
0.8561 High Similarity NPC40377
0.8553 High Similarity NPC137460
0.8553 High Similarity NPC78809
0.8542 High Similarity NPC87777
0.8542 High Similarity NPC262328
0.8531 High Similarity NPC238243
0.8526 High Similarity NPC472153
0.8523 High Similarity NPC204770
0.8523 High Similarity NPC263940
0.8523 High Similarity NPC236202
0.8523 High Similarity NPC82917
0.8523 High Similarity NPC108811
0.8523 High Similarity NPC202742
0.8523 High Similarity NPC170103
0.8523 High Similarity NPC262911
0.8523 High Similarity NPC227902
0.8523 High Similarity NPC294558
0.8523 High Similarity NPC18185
0.8523 High Similarity NPC70409
0.8523 High Similarity NPC58190
0.8514 High Similarity NPC277867
0.8514 High Similarity NPC161700
0.85 High Similarity NPC97326
0.8493 Intermediate Similarity NPC100482
0.8493 Intermediate Similarity NPC277331
0.8493 Intermediate Similarity NPC210192
0.8493 Intermediate Similarity NPC178054
0.8487 Intermediate Similarity NPC59692
0.8477 Intermediate Similarity NPC238140
0.8472 Intermediate Similarity NPC197723
0.8472 Intermediate Similarity NPC138350
0.8472 Intermediate Similarity NPC3293
0.8472 Intermediate Similarity NPC40664
0.8472 Intermediate Similarity NPC475628
0.8472 Intermediate Similarity NPC165482
0.8467 Intermediate Similarity NPC281549
0.8462 Intermediate Similarity NPC87696
0.8456 Intermediate Similarity NPC99515
0.8456 Intermediate Similarity NPC96576
0.8456 Intermediate Similarity NPC190714
0.8452 Intermediate Similarity NPC147743
0.8452 Intermediate Similarity NPC73517
0.8452 Intermediate Similarity NPC4809
0.8451 Intermediate Similarity NPC165686
0.8451 Intermediate Similarity NPC26080
0.8451 Intermediate Similarity NPC85799
0.8451 Intermediate Similarity NPC303422
0.8435 Intermediate Similarity NPC475084
0.8435 Intermediate Similarity NPC145319
0.8425 Intermediate Similarity NPC106944
0.8421 Intermediate Similarity NPC473621
0.8421 Intermediate Similarity NPC259707
0.8421 Intermediate Similarity NPC471403
0.8418 Intermediate Similarity NPC120677
0.8418 Intermediate Similarity NPC74371
0.8414 Intermediate Similarity NPC134260
0.8411 Intermediate Similarity NPC476969
0.8411 Intermediate Similarity NPC211561
0.8411 Intermediate Similarity NPC321657
0.8411 Intermediate Similarity NPC44452
0.8411 Intermediate Similarity NPC318373
0.8405 Intermediate Similarity NPC272656
0.8403 Intermediate Similarity NPC79957
0.8397 Intermediate Similarity NPC185231
0.8397 Intermediate Similarity NPC159526
0.8397 Intermediate Similarity NPC106601
0.8397 Intermediate Similarity NPC471404
0.8397 Intermediate Similarity NPC472156
0.8397 Intermediate Similarity NPC86630
0.8397 Intermediate Similarity NPC205613
0.8397 Intermediate Similarity NPC212614
0.8397 Intermediate Similarity NPC151474
0.8392 Intermediate Similarity NPC294166
0.8392 Intermediate Similarity NPC115022
0.8389 Intermediate Similarity NPC475096
0.838 Intermediate Similarity NPC121376
0.838 Intermediate Similarity NPC284232
0.8378 Intermediate Similarity NPC473044
0.8369 Intermediate Similarity NPC218003
0.8367 Intermediate Similarity NPC257095
0.8367 Intermediate Similarity NPC89686
0.8367 Intermediate Similarity NPC469661
0.8367 Intermediate Similarity NPC273932
0.8367 Intermediate Similarity NPC471389
0.8367 Intermediate Similarity NPC108674
0.8366 Intermediate Similarity NPC474442
0.8365 Intermediate Similarity NPC75944
0.8356 Intermediate Similarity NPC471388
0.8355 Intermediate Similarity NPC214326
0.8355 Intermediate Similarity NPC9933
0.8355 Intermediate Similarity NPC218041
0.8355 Intermediate Similarity NPC260781
0.8355 Intermediate Similarity NPC182368
0.8355 Intermediate Similarity NPC469706
0.8355 Intermediate Similarity NPC185955
0.8355 Intermediate Similarity NPC225815
0.8355 Intermediate Similarity NPC145979
0.8355 Intermediate Similarity NPC469707
0.8345 Intermediate Similarity NPC104167
0.8345 Intermediate Similarity NPC234952
0.8345 Intermediate Similarity NPC242028
0.8345 Intermediate Similarity NPC203230
0.8344 Intermediate Similarity NPC227516
0.8344 Intermediate Similarity NPC20757
0.8333 Intermediate Similarity NPC215678
0.8333 Intermediate Similarity NPC274454
0.8322 Intermediate Similarity NPC225445
0.8322 Intermediate Similarity NPC25292
0.8322 Intermediate Similarity NPC473045
0.8322 Intermediate Similarity NPC304894
0.8322 Intermediate Similarity NPC473108
0.8322 Intermediate Similarity NPC15659
0.8322 Intermediate Similarity NPC50250
0.8313 Intermediate Similarity NPC472150
0.8311 Intermediate Similarity NPC49542
0.8311 Intermediate Similarity NPC5253
0.8311 Intermediate Similarity NPC139976
0.8311 Intermediate Similarity NPC60249
0.8311 Intermediate Similarity NPC230718
0.8311 Intermediate Similarity NPC128337
0.8311 Intermediate Similarity NPC84207
0.8311 Intermediate Similarity NPC189115
0.8311 Intermediate Similarity NPC469559
0.8299 Intermediate Similarity NPC262189
0.8298 Intermediate Similarity NPC311293
0.8298 Intermediate Similarity NPC148366
0.8291 Intermediate Similarity NPC48880
0.8288 Intermediate Similarity NPC211549
0.8288 Intermediate Similarity NPC176051
0.8288 Intermediate Similarity NPC65530
0.8288 Intermediate Similarity NPC102904
0.8288 Intermediate Similarity NPC103976
0.8288 Intermediate Similarity NPC138738
0.8288 Intermediate Similarity NPC474282
0.8288 Intermediate Similarity NPC107551
0.8288 Intermediate Similarity NPC59324
0.8288 Intermediate Similarity NPC326797
0.8288 Intermediate Similarity NPC470413
0.8278 Intermediate Similarity NPC99183
0.8278 Intermediate Similarity NPC174251
0.8278 Intermediate Similarity NPC474397
0.8278 Intermediate Similarity NPC153182
0.8276 Intermediate Similarity NPC61946
0.8276 Intermediate Similarity NPC164787
0.8276 Intermediate Similarity NPC472337
0.8267 Intermediate Similarity NPC138915
0.8267 Intermediate Similarity NPC272619
0.8267 Intermediate Similarity NPC11422
0.8267 Intermediate Similarity NPC178014
0.8267 Intermediate Similarity NPC42716
0.8267 Intermediate Similarity NPC307466
0.8267 Intermediate Similarity NPC474749
0.8267 Intermediate Similarity NPC286245

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC23807 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8354 Intermediate Similarity NPD3787 Discontinued
0.8194 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8194 Intermediate Similarity NPD1613 Approved
0.8058 Intermediate Similarity NPD1091 Approved
0.8037 Intermediate Similarity NPD3751 Discontinued
0.7972 Intermediate Similarity NPD2861 Phase 2
0.7935 Intermediate Similarity NPD1653 Approved
0.7917 Intermediate Similarity NPD4908 Phase 1
0.7917 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7881 Intermediate Similarity NPD6674 Discontinued
0.7847 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7808 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7799 Intermediate Similarity NPD8455 Phase 2
0.774 Intermediate Similarity NPD3027 Phase 3
0.7711 Intermediate Similarity NPD7228 Approved
0.7676 Intermediate Similarity NPD1610 Phase 2
0.7665 Intermediate Similarity NPD7054 Approved
0.7647 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7632 Intermediate Similarity NPD7266 Discontinued
0.7619 Intermediate Similarity NPD7472 Approved
0.7619 Intermediate Similarity NPD7074 Phase 3
0.7619 Intermediate Similarity NPD4625 Phase 3
0.7574 Intermediate Similarity NPD6797 Phase 2
0.7546 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7544 Intermediate Similarity NPD8313 Approved
0.7544 Intermediate Similarity NPD8312 Approved
0.7529 Intermediate Similarity NPD7251 Discontinued
0.7518 Intermediate Similarity NPD1548 Phase 1
0.7516 Intermediate Similarity NPD37 Approved
0.7515 Intermediate Similarity NPD7199 Phase 2
0.75 Intermediate Similarity NPD6234 Discontinued
0.7485 Intermediate Similarity NPD7808 Phase 3
0.7485 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD4965 Approved
0.7485 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD4966 Approved
0.7485 Intermediate Similarity NPD6166 Phase 2
0.7485 Intermediate Similarity NPD4967 Phase 2
0.7467 Intermediate Similarity NPD4060 Phase 1
0.7456 Intermediate Similarity NPD5844 Phase 1
0.7443 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD4749 Approved
0.7326 Intermediate Similarity NPD7240 Approved
0.7325 Intermediate Similarity NPD2677 Approved
0.7321 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD7097 Phase 1
0.7317 Intermediate Similarity NPD5402 Approved
0.731 Intermediate Similarity NPD3705 Approved
0.7305 Intermediate Similarity NPD6959 Discontinued
0.7305 Intermediate Similarity NPD6671 Approved
0.7296 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7294 Intermediate Similarity NPD3818 Discontinued
0.7278 Intermediate Similarity NPD5058 Phase 3
0.7195 Intermediate Similarity NPD1934 Approved
0.7179 Intermediate Similarity NPD5762 Approved
0.7179 Intermediate Similarity NPD5763 Approved
0.7178 Intermediate Similarity NPD4380 Phase 2
0.7172 Intermediate Similarity NPD5126 Approved
0.7172 Intermediate Similarity NPD5125 Phase 3
0.7171 Intermediate Similarity NPD6233 Phase 2
0.7161 Intermediate Similarity NPD5960 Phase 3
0.7158 Intermediate Similarity NPD6780 Approved
0.7158 Intermediate Similarity NPD6778 Approved
0.7158 Intermediate Similarity NPD6781 Approved
0.7158 Intermediate Similarity NPD6782 Approved
0.7158 Intermediate Similarity NPD6779 Approved
0.7158 Intermediate Similarity NPD6777 Approved
0.7158 Intermediate Similarity NPD6776 Approved
0.7153 Intermediate Similarity NPD968 Approved
0.7152 Intermediate Similarity NPD1465 Phase 2
0.7152 Intermediate Similarity NPD2801 Approved
0.7152 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD6559 Discontinued
0.7125 Intermediate Similarity NPD7212 Phase 2
0.7125 Intermediate Similarity NPD7213 Phase 3
0.7101 Intermediate Similarity NPD290 Approved
0.7097 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD4536 Approved
0.7097 Intermediate Similarity NPD4538 Approved
0.7089 Intermediate Similarity NPD1652 Phase 2
0.7081 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD6823 Phase 2
0.7081 Intermediate Similarity NPD7447 Phase 1
0.7078 Intermediate Similarity NPD5735 Approved
0.707 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD7157 Approved
0.7062 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD5588 Approved
0.7047 Intermediate Similarity NPD6696 Suspended
0.7047 Intermediate Similarity NPD8651 Approved
0.7044 Intermediate Similarity NPD3750 Approved
0.7044 Intermediate Similarity NPD3892 Phase 2
0.7043 Intermediate Similarity NPD7696 Phase 3
0.7043 Intermediate Similarity NPD7698 Approved
0.7043 Intermediate Similarity NPD7697 Approved
0.7043 Intermediate Similarity NPD7435 Discontinued
0.702 Intermediate Similarity NPD3018 Phase 2
0.7013 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD3620 Phase 2
0.7012 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7007 Intermediate Similarity NPD3496 Discontinued
0.7006 Intermediate Similarity NPD8054 Approved
0.7006 Intermediate Similarity NPD8053 Approved
0.7 Intermediate Similarity NPD6190 Approved
0.6994 Remote Similarity NPD5403 Approved
0.6993 Remote Similarity NPD6798 Discontinued
0.6993 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6989 Remote Similarity NPD7549 Discontinued
0.6984 Remote Similarity NPD7701 Phase 2
0.698 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6975 Remote Similarity NPD7446 Clinical (unspecified phase)
0.6972 Remote Similarity NPD7843 Approved
0.6968 Remote Similarity NPD5124 Phase 1
0.6968 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6954 Remote Similarity NPD6917 Clinical (unspecified phase)
0.6946 Remote Similarity NPD7819 Suspended
0.6941 Remote Similarity NPD5494 Approved
0.6939 Remote Similarity NPD5846 Approved
0.6939 Remote Similarity NPD6516 Phase 2
0.6933 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6933 Remote Similarity NPD1940 Clinical (unspecified phase)
0.6932 Remote Similarity NPD7685 Pre-registration
0.6929 Remote Similarity NPD2684 Approved
0.6928 Remote Similarity NPD7095 Approved
0.6927 Remote Similarity NPD4663 Approved
0.6923 Remote Similarity NPD7075 Discontinued
0.6919 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6915 Remote Similarity NPD7870 Phase 2
0.6915 Remote Similarity NPD7871 Phase 2
0.6914 Remote Similarity NPD1511 Approved
0.6905 Remote Similarity NPD3817 Phase 2
0.6905 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6903 Remote Similarity NPD2238 Phase 2
0.6903 Remote Similarity NPD4140 Approved
0.6899 Remote Similarity NPD6099 Approved
0.6899 Remote Similarity NPD6100 Approved
0.6889 Remote Similarity NPD7906 Approved
0.6885 Remote Similarity NPD6535 Approved
0.6885 Remote Similarity NPD6534 Approved
0.6875 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7007 Discovery
0.6875 Remote Similarity NPD7783 Phase 2
0.6871 Remote Similarity NPD1357 Approved
0.6871 Remote Similarity NPD5401 Approved
0.6867 Remote Similarity NPD2983 Phase 2
0.6867 Remote Similarity NPD2982 Phase 2
0.6865 Remote Similarity NPD7699 Phase 2
0.6865 Remote Similarity NPD7700 Phase 2
0.6862 Remote Similarity NPD7680 Approved
0.686 Remote Similarity NPD6232 Discontinued
0.6859 Remote Similarity NPD6355 Discontinued
0.6855 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6855 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6854 Remote Similarity NPD4578 Approved
0.6854 Remote Similarity NPD4577 Approved
0.6846 Remote Similarity NPD1611 Approved
0.6846 Remote Similarity NPD422 Phase 1
0.6845 Remote Similarity NPD5929 Approved
0.6842 Remote Similarity NPD6584 Phase 3
0.6835 Remote Similarity NPD2154 Approved
0.6835 Remote Similarity NPD4108 Discontinued
0.6835 Remote Similarity NPD2155 Approved
0.6835 Remote Similarity NPD7033 Discontinued
0.6835 Remote Similarity NPD2156 Approved
0.6832 Remote Similarity NPD4628 Phase 3
0.6829 Remote Similarity NPD1512 Approved
0.6828 Remote Similarity NPD709 Approved
0.6824 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6823 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6823 Remote Similarity NPD7874 Approved
0.6821 Remote Similarity NPD3225 Approved
0.6815 Remote Similarity NPD6653 Approved
0.6813 Remote Similarity NPD1549 Phase 2
0.6813 Remote Similarity NPD7037 Approved
0.681 Remote Similarity NPD7040 Clinical (unspecified phase)
0.681 Remote Similarity NPD6143 Clinical (unspecified phase)
0.681 Remote Similarity NPD7041 Phase 2
0.6806 Remote Similarity NPD5283 Phase 1
0.6806 Remote Similarity NPD1398 Phase 1
0.6802 Remote Similarity NPD8127 Discontinued
0.68 Remote Similarity NPD2231 Phase 2
0.68 Remote Similarity NPD2981 Phase 2
0.68 Remote Similarity NPD2235 Phase 2
0.6788 Remote Similarity NPD7801 Approved
0.6783 Remote Similarity NPD228 Approved
0.6782 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6781 Remote Similarity NPD7340 Approved
0.6776 Remote Similarity NPD3094 Phase 2
0.6772 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6771 Remote Similarity NPD8151 Discontinued
0.677 Remote Similarity NPD5061 Approved
0.677 Remote Similarity NPD5177 Phase 3
0.677 Remote Similarity NPD5062 Approved
0.6765 Remote Similarity NPD7768 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data